A team from Helmholtz Munich developed MemBrain v2, an AI tool that automates the analysis of cell membranes in 3D images, cutting work from weeks to hours. The tool locates specific membrane proteins and analyzes their spatial arrangement, showing how cellular processes are organized at the molecular level.
Researchers at Helmholtz Munich developed Synthetic Transfer Vehicles (STVs), an entirely new class of RNA transporters. STV-C8 is the most efficient candidate, transporting RNA far more efficiently than traditional lipid nanoparticles. In animal models, STV-C8 demonstrates effective delivery and expression of RNA in a living organism.
Researchers at Helmholtz Munich have identified a tumor protein called ADAMTSL4 as a key driver of cancer cachexia, a wasting process that affects muscle and fat tissue. The protein locally activates the TGF-β signaling pathway, triggering a catabolic program that promotes muscle and fat breakdown.
Researchers found cytoskeletal proteins in cell nuclei of neural stem cells, influencing developmental programs. MAP1B protein helps maintain stem cell state for longer, contributing to abnormal brain development.
Researchers have found that screening for early-stage type 1 diabetes in children can be implemented sustainably in general pediatric practice, identifying most children who will later develop stage 3 clinical type 1 diabetes. The study suggests that families without a family history of the disease should also be screened.
Researchers developed an AI framework, MouseMapper, to map disease-related changes in the entire mouse body. They found widespread inflammation and previously unrecognized damage to facial sensory nerves caused by obesity, which was also observed in human tissue.
A new approach for treating obesity and type 2 diabetes has been developed using a hybrid molecule that targets specific cells. The treatment combines the well-known GLP-1/GIP signalling pathway with an additional metabolic modulator, delivering improved blood-glucose values and weight loss.
A new microscopy method can distinguish lipid species in living cells using mid-infrared illumination and optoacoustic detection, producing a unique spectral fingerprint. This approach eliminates the need for chemical labels, reducing stress on cells and enabling real-time lipid mapping.
EDENT1FI has screened 100,000 children across Europe for early-stage type 1 diabetes, using standardized screening programs and harmonized data collection. The initiative aims to empower families to manage life with type 1 diabetes effectively and support children and adolescents with early-stage detection.
A global genomics study reveals that genetic variants influence gene activity and protein abundance in multiple tissues, not just blood samples. This analysis identifies causal evidence for 676 genes linked to type 2 diabetes.
Researchers at Helmholtz Munich discovered that gut bacteria can directly deliver proteins into human cells, shaping immune responses. This new mechanism may help explain how changes in gut bacteria contribute to inflammatory diseases like Crohn's disease.
Researchers developed a new imaging technology called fast-RSOM that captures detailed images of the smallest blood vessels directly through the skin. This technology can detect early signs of cardiovascular risk, enabling doctors to intervene sooner and guide personalized therapies.
BioPathNet is an AI method that analyzes large biomedical knowledge graphs to identify hidden connections between genes, diseases, and drugs. The model proposes hypotheses that can be tested experimentally or clinically, providing a hypothesis-generating tool for researchers.
Researchers mapped nearly 400 genetic regions regulating circulating proteins, identifying 18 with a likely causal link to T2D. These findings provide new insights into disease biology and could lead to earlier and more accurate diagnoses, as well as treatments tailored to African populations.
Researchers at Helmholtz Munich uncovered a mechanism that protects nerve cells from premature cell death, known as ferroptosis. A single mutation in the GPX4 gene disrupts its function, leading to severe neurodegeneration in children with early-onset dementia.
The C-COMPASS tool uses neural networks to predict protein localizations and incorporates proteome data for reproducible analyses. It enables the exploration of spatial lipidomics by combining proteome and lipidome data, revealing changes in lipid distribution associated with metabolic perturbations.
The POInT trial reveals promising secondary findings: oral insulin delays clinical type 1 diabetes progression, especially in children with high-risk insulin gene variants. This opens doors to targeted, personalized prevention strategies for a genetically defined subgroup of children.
A new study found that maternal type 1 diabetes is associated with specific epigenetic marks in the child, which affect immune function and expression of genes involved in autoimmune diseases. These changes appear to protect against islet autoimmunity, a precursor to type 1 diabetes.
Researchers developed Nicheformer, an AI model that learns from both dissociated and spatial data to reconstruct cell identity and tissue organization. The model shows measurable traces in gene expression even when cells are dissociated, offering new insights into how AI learns from biology.
A new technology enables early detection of esophageal cancer by combining optical coherence tomography and optoacoustic imaging to visualize tissue structure and function. This could reduce treatment costs from €140,000 to €10,000 per patient.
The TherVacB vaccine aims to activate the natural immune response to eliminate the hepatitis B virus. In a new phase 1b/2a clinical trial, 81 patients will receive increasing doses of the vaccine components to determine its safety and effectiveness.
Researchers at Helmholtz Munich discovered that liver metabolism is reprogrammed in cachexia, with a specific gene called REV-ERBα being almost completely shut down. This 'internal clock' regulates liver-derived signaling molecules that drive disease progression and promote physical wasting.
MiROM identifies proteins by detecting molecular vibrations and detects structural changes in proteins, such as misfolding, allowing for real-time assessments of treatment effectiveness. This technology holds great potential for other diseases linked to protein misfolding, including Alzheimer's and Parkinson's.
Researchers have launched an open-source platform to benchmark, improve and run competitions for single-cell genomics computational methods. The platform standardizes evaluations, fosters reproducibility and accelerates progress towards open challenges in this fast-moving field.
Researchers at Helmholtz Munich developed an AI model called Centaur that can simulate human behavior with remarkable accuracy. It was trained on over ten million decisions from psychological experiments and makes decisions that closely resemble those of real people. The model opens new avenues for understanding human cognition and imp...
A new microscope, QIScope, significantly improves bioluminescence imaging by detecting extremely low levels of light. It offers higher sensitivity, improved resolution, and a wider field of view, allowing researchers to track subtle changes in living cells over extended periods.
Large language models perform well in games that require logical reasoning, but struggle with tasks that demand teamwork and coordination. Researchers implemented a technique called Social Chain-of-Thought (SCoT) to encourage more socially aware behavior, resulting in significant improvements.
A new AI algorithm can automatically assess stent healing in OCT images, differentiating between healthy and unhealthy tissue with high accuracy. This technology has the potential to improve clinical decision-making and reduce healthcare costs by providing precise measurements and valuable insights for patient management.
A study led by Helmholtz Munich found that epigenetic programs play a crucial role in DNA self-organization in early embryos. The researchers discovered multiple parallel regulatory pathways controlling nuclear organization, which can self-correct errors even after the first cell division.
The Helmholtz Health Prevention Task Force aims to develop new frameworks for prevention strategies using big data and advanced analytics. The team focuses on personalized health trends and risk factors to enable earlier detection and intervention for common diseases.
The largest genome-wide association study on osteoarthritis identifies over 900 genetic associations, including 700 genes involved in the disease. These findings offer new insights into the genetic landscape of osteoarthritis and potential drug repurposing opportunities.
ENVLPE addresses limitations of previous gene editing delivery systems by hijacking intracellular transport mechanisms to ensure efficient packaging and protection of gene editors. The system was tested in a mouse model of inherited blindness, achieving astounding restoration of vision, and has potential for cancer therapy advancements
Researchers at Helmholtz Munich identified distinct subtypes of white matter astrocytes, including one that can multiply and support brain repair. These findings raise possibilities for regenerative medicine and therapies for brain injuries and neurodegenerative diseases.
The Adiposetissue.org platform integrates transcriptomic, proteomic, and clinical data from over 6,000 individuals to explore obesity-related changes and weight-loss effects. Researchers can now analyze comprehensive datasets without bioinformatics expertise.
A groundbreaking AI tool called Moscot maps single cells in spatial tissues, enabling the observation of millions of cells simultaneously. This allows researchers to analyze complex cellular processes within entire living organs and organisms, providing new insights into diseases like diabetes.
A study by researchers at Helmholtz Munich has discovered that ancient viral DNA elements are re-expressed in mammalian embryos, playing a crucial role in early development. The activation of these elements is conserved across species and provides opportunities for manipulating thousands of genes simultaneously.
Researchers use SCP-Nano to analyze distribution of extremely low doses of nanocarriers throughout the mouse body, visualizing each cell that has taken them up. The platform identifies unwanted accumulation in organs like the heart and liver, paving the way for safer mRNA therapeutics.
Researchers have identified a molecular strategy employed by worm parasites to evade host immune defenses, offering promising solutions for addressing major infectious diseases, allergies, and asthma. By analyzing the unique immune-regulatory properties of helminths, scientists pinpointed key features essential to their activity.
Researchers at Helmholtz Munich identified a mechanism explaining Long COVID's neurological symptoms: SARS-CoV-2 spike protein remains in the brain for up to four years after infection. mRNA COVID-19 vaccines significantly reduce spike protein accumulation, but persistent presence poses a toxic risk.
Researchers discovered Inceptor's role in regulating insulin homeostasis and its potential to improve beta cell function. By blocking Inceptor, the receptor can refill beta cells' insulin stores and enhance insulin release.
An international study found that extremely heavy rainfall, occurring every five years, significantly increases mortality rates worldwide. The impacts vary greatly by region, depending on local climate and environmental conditions.
Ehrapy allows researchers to analyze large, heterogeneous datasets efficiently, uncovering new patterns and generating insights. The long-term goal of ehrapy is to provide a powerful tool for the research community and eventually standardize databases for electronic health records.
A global study using data from the Multi-Country Multi-City Collaborative Research Network found that air pollution remains a significant threat to public health, despite lower pollutant concentrations. The study analyzed the impact of particulate matter and nitrogen dioxide on mortality rates in urban areas over a 22-year period.
Research at Helmholtz Munich found that a father's body weight can affect the weight of their child and increase susceptibility to metabolic diseases. The study suggests that paternal diet influences gene expression in early embryos, affecting the development and health of offspring.
A recent study found that extreme night-time temperatures significantly increase the risk of stroke, with a 7% increase in risk compared to non-extreme nights. Elderly people and women are particularly at risk, with mild symptoms often diagnosed after hot nights.
A new study aims to investigate whether vaccination against SARS-CoV-2 can protect children at increased genetic risk of developing type 1 diabetes. The AVAnT1A Study, the largest intervention study to date, examines the relationship between viral infections and early childhood development.
A team of scientists has identified a specific gene expression pattern associated with an increased risk of childhood asthma. By understanding this mechanism, they aim to develop novel drugs that can correct the defense defect and prevent the progression of the disease.
A recent study by Helmholtz Munich scientists has made significant breakthroughs in understanding how epigenetic modifications work together to regulate the genome. The research sheds light on the complex interactions between DNA, histone proteins, and epigenetic reader proteins, providing new insights into diseases such as cancer, met...
A novel study in mice with diet-induced obesity demonstrates that the knock-out of inceptor enhances glucose regulation, prompting its exploration as a drug target for type 2 diabetes treatment. Inhibiting inceptor function may enhance insulin signaling, required for beta cell function and survival.
Researchers at Helmholtz Munich have discovered a new relationship between DNA replication timing and cellular plasticity, allowing for the potential reprogramming of cells. The study found that the three-dimensional structure of the genome influences the flexibility of the replication timing program.